» Articles » PMID: 32258797

Potential Role of Macrophage Migration Inhibitory Factor in the Pathogenesis of Marek's Disease

Overview
Journal J Vet Res
Publisher Sciendo
Date 2020 Apr 8
PMID 32258797
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Marek's disease virus (MDV) can cause malignant T-cell lymphomas and immunosuppression in chickens. Macrophage migration inhibitory factor (MIF) not only plays a critical role in inhibiting T-cell responses, but also contributes to multiple aspects of tumour progression. The aim of this study was to reveal the potential role of MIF in the pathogenesis of MDV infection.

Material And Methods: MIF gene expression levels were measured by using real-time PCR. Expression was assayed at different times in chicken embryo fibroblast (CEF) cells and tissue samples of SPF chickens infected with different MDV strains and fold change was calculated by the 2 method.

Results: The expression of MIF was significantly downregulated (p < 0.05 and FC > 2) in CEF cells infected with the very virulent MDV RB1B strain at 48 h post infection (hpi) and in the skin and spleen at 14 days post infection (dpi). The reduction of MIF expression was also found in CEF cells infected by reticuloendotheliosis virus (REV), avian leukosis virus subgroup J (ALV-J), and MDV vaccine strain CVI988 or in HD11 cells stimulated with TLR2, 3, 4, and 7 ligands. Interestingly, MIF expression decreased continuously from 7 to 28 dpi in the thymus after RB1B virus infection while it increased after CVI988 virus infection. Upregulated expression of MIF was found in CEF infected with RB1B at 96 hpi and in the spleen and skin at 21 and 28 dpi.

Conclusion: The present study revealed the different expression pattern of MIF in response to MDV infection and indicated that MIF level may be associated with MDV pathogenesis.

Citing Articles

Immune escape of avian oncogenic Marek's disease herpesvirus and antagonistic host immune responses.

Zhu Z, Teng M, Liu Y, Chen F, Yao Y, Li E NPJ Vaccines. 2024; 9(1):109.

PMID: 38879650 PMC: 11180173. DOI: 10.1038/s41541-024-00905-0.

References
1.
Mitchell R, Liao H, Chesney J, Fingerle-Rowson G, Baugh J, David J . Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci U S A. 2002; 99(1):345-50. PMC: 117563. DOI: 10.1073/pnas.012511599. View

2.
Oda S, Oda T, Nishi K, Takabuchi S, Wakamatsu T, Tanaka T . Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One. 2008; 3(5):e2215. PMC: 2375051. DOI: 10.1371/journal.pone.0002215. View

3.
Zhou Q, Yan X, Gershan J, Orentas R, Johnson B . Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo. J Immunol. 2008; 181(3):1877-86. PMC: 3804024. DOI: 10.4049/jimmunol.181.3.1877. View

4.
Schinagl A, Thiele M, Douillard P, Volkel D, Kenner L, Kazemi Z . Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer. Oncotarget. 2016; 7(45):73486-73496. PMC: 5341993. DOI: 10.18632/oncotarget.11970. View

5.
Osterrieder N, Kamil J, Schumacher D, Tischer B, Trapp S . Marek's disease virus: from miasma to model. Nat Rev Microbiol. 2006; 4(4):283-94. DOI: 10.1038/nrmicro1382. View